Bergen, Norway 4 June 2022
Lifecare achieved the two major milestones for 1H2022 in June, the clinical study announced 23 June has started and Lifecare continue to strengthen the organization. Read more in the Lifecare July newsletter: https://lifecare.no/news/information-from-lifecare-july-2022/
This is Lifecare
Lifecare is a Bergen-based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The Company's patented technology also has the potential for use in various biomarkers. Lifecare AS is listed on Euronext Growth (LIFE).
Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40
This stock exchange announcement was published by Joacim Holter, CEO at Lifecare AS, on 04.07.22 at 08:59 CET.